Covestor
XENE icon

Covestor’s Xenon Pharmaceuticals XENE Stock Holding History

Covestor’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$25K Buy
674
+544
+418% +$32.3K 0.02% 1035
2026
Q2 		$8K Buy
130
+120
+1,200% +$6.66K ﹤0.01% 1757
2026
Q1 		$1K Sell
10
-237
-96% -$10.9K ﹤0.01% 2178
2025
Q4 		$11K Buy
247
+244
+8,133% +$10.2K 0.01% 1549
2025
Q3 		$0 Buy
+3
New +$106 ﹤0.01% 2849

Other funds holding XENE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $102B AUM 35.16% 1-Year Est. Return

Covestor's XENE Position: Q3 2026 in Review

Covestor increased its Xenon Pharmaceuticals (XENE) stake by 418% in Q3 2026, buying an estimated $32.3K and bringing the position to 674 shares worth $25K. The position accounts for 0.02% of the portfolio, ranked #1035.

Covestor first reported a position in XENE in Q3 2025 and has held it in 5 quarters since. 196 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • Covestor held 674 shares of Xenon Pharmaceuticals worth $25K as of Q3 2026.
  • Covestor bought 544 Xenon Pharmaceuticals shares in Q3 2026, an estimated $32.3K.
  • Xenon Pharmaceuticals made up 0.02% of Covestor's portfolio in Q3 2026, its #1035 holding.
  • Covestor first reported a position in Xenon Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • 196 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.